These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2556982)

  • 21. Efficacy of a virion envelope herpes simplex virus vaccine against experimental skin infections in hairless mice.
    Klein RJ; Buimovici-Klein E; Moser H; Moucha R; Hilfenhaus J
    Arch Virol; 1981; 68(2):73-80. PubMed ID: 6264897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes simplex virus subunit vaccine: characterization of the virus strain used and testing of the vaccine.
    Hilfenhaus J; Moser H; Herrmann A; Mauler R
    Dev Biol Stand; 1982; 52():321-31. PubMed ID: 6299841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
    Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
    Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells.
    Ghasemi M; Erturk M; Buruk K; Sonmez M
    Cytotherapy; 2013 Mar; 15(3):352-61. PubMed ID: 23579060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation of experimental murine herpes simplex keratitis: II. Glycoprotein D protection.
    Foster CS; Sandstrom IK; Wells PA; Thompson P; Daigle J; Opremcak EM
    Curr Eye Res; 1988 Nov; 7(11):1051-61. PubMed ID: 2854037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute and latent infection of mice immunised with HSV-1 ISCOM vaccine.
    Erturk M; Hill TJ; Shimeld C; Jennings R
    Arch Virol; 1992; 125(1-4):87-101. PubMed ID: 1642562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate and acquired immunity to herpes simplex virus type 1.
    Halford WP; Veress LA; Gebhardt BM; Carr DJ
    Virology; 1997 Sep; 236(2):328-37. PubMed ID: 9325240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine.
    Kino Y
    Adv Exp Med Biol; 1990; 278():183-90. PubMed ID: 1963033
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice.
    Klein RJ
    J Gen Virol; 1980 Aug; 49(2):401-5. PubMed ID: 6255074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of asymptomatic initial herpes simplex virus (HSV) infections in animals immunized with subunit HSV glycoprotein vaccines.
    Bernstein DI; Ashley RL; Stanberry LR; Myers MG
    J Clin Microbiol; 1990 Jan; 28(1):11-5. PubMed ID: 2153698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2.
    Walz MA; Price RW; Hayashi K; Katz BJ; Notkins AL
    J Infect Dis; 1977 May; 135(5):744-52. PubMed ID: 192810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.
    Ghazi HO; Erturk M; Stannard LM; Faulkner M; Potter CW; Jennings R
    Arch Virol; 1995; 140(6):1015-31. PubMed ID: 7611875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection.
    Willey DE; Cantin EM; Hill LR; Moss B; Notkins AL; Openshaw H
    J Infect Dis; 1988 Dec; 158(6):1382-6. PubMed ID: 2848904
    [No Abstract]   [Full Text] [Related]  

  • 37. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge.
    Ghiasi H; Roopenian DC; Slanina S; Cai S; Nesburn AB; Wechsler SL
    Immunology; 1997 Jul; 91(3):430-5. PubMed ID: 9301533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
    Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.
    Mishkin EM; Fahey JR; Kino Y; Klein RJ; Abramovitz AS; Mento SJ
    Vaccine; 1991 Mar; 9(3):147-53. PubMed ID: 1645898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.